All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Bizay Raises $55M Series D to Expand SMB Marketplace in U.S.

The Lisbon-based custom products platform, led by CEO José Salgado, will use the Indico-led round to challenge Vistaprint and Custom Ink with its 'fabless' supply chain model.

Read the full article
Dara Okafor3d agoen

You might also wanna read

Portugal's BIZAY raises $55M Series D to expand US presence and consolidate the customized products market

BIZAY, a Portugal-based technology platform for customised products, has raised $55 million in a Series D funding round. The investment was

tech.eu·11d ago

Portugal's BIZAY raises $55M Series D to expand US presence and consolidate the customized products market

BIZAY, a Portugal-based technology platform for customised products, has raised $55 million in a Series D funding round. The investment was

Tech.eu·11d ago

Emergent Raises Series C at $1.5B Valuation to Help Entrepreneurs and SMBs Build the Software Their Businesses Run On

Creaegis led the round, with Claypond and Sentinel Global co-leading and participation from Khosla Ventures, SoftBank Vision Fund 2, Lightsp

iTWire·2d ago

From suppliers to brand owners: How India’s SMEs are tapping a $250 billion e-commerce opportunity

integrated commerce platforms are enabling SMEs to build brands, acquire customers, streamline fulfilment, access financing and expand acros

thehindubusinessline.com·7d ago

Maneva raises $27-million USD Series A to expand AI vision in manufacturing

Capital will be used to scale into North America, expand into Asian markets. The post Maneva raises $27-million USD Series A to expand AI vi

BetaKit·1mo ago

Abivax CEO says $920M raise lets it launch its bowel disease drug in the U.S. solo

The French biotech plans to use proceeds to commercialize obefazimod in the U.S. through 2029, CEO Marc de Garidel told CNBC

Quartz·7d ago

Abivax CEO says $920M raise lets it launch its bowel disease drug in the U.S. solo

The French biotech plans to use proceeds to commercialize obefazimod in the U.S. through 2029, CEO Marc de Garidel told CNBC

qz.com·7d ago

Modern Financial Platform for Small and Medium Businesses Launches on Product Hunt

Rebuilds the Financial stack around context, not rigid workflows, so business finance finally feels intuitive.

Product Hunt·1y ago

Comments

Sign in to join the conversation.

No comments yet. Be the first.